Anti-Cytokeratin 18 Purified

*Kovarik J, Rejthar A, Lauerova L, Vojtesek B, Bartkova J: Monoclonal antibodies against individual cytokeratins in the detection of metastatic spread. Int J Cancer Suppl. 1988;3:50-5., URL: https://www.ncbi.nlm.nih.gov/pubmed/2463228?dopt=A, *Lauerova L, Kovarik J, Bartek J, Rejthar A, Vojtesek B: Novel monoclonal antibodies defining epitope of human cytokeratin 18 molecule. Hybridoma. 1988 Oct;7 (5) :495-504. , URL: https://www.ncbi.nlm.nih.gov/pubmed/2461901?dopt=A, *Lauerova L, Kovarik J, Bartek J, Rejthar A, Vojtesek B: Novel monoclonal antibodies defining epitope of human cytokeratin 18 molecule. Hybridoma. 1988 Oct;7 (5) :495-504., URL: https://www.ncbi.nlm.nih.gov/pubmed/2461901?dopt=A

*Čáp J, Čermáň J, Němeček S, Marková M, Haná V, Frysák Z: The influence of treatment with somatostatin analogues on morphology, proliferative and apoptotic activity in GH-secreting pituitary adenomas. J Clin Neurosci. 2003 Jul;10 (4) :444-8. , URL: https://www.ncbi.nlm.nih.gov/pubmed/12852883?dopt=, *Kovařík J. et al., J. Tumor Marker Oncol. 5, 219 (1990) ., URL: , *Taylor-Papadimitriou J, Stampfer M, Bártek J, Lewis A, Boshell M, Lane EB, Leigh IM: Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci. 1989 Nov;94 (Pt 3) :403-13., URL: https://www.ncbi.nlm.nih.gov/pubmed/2483723?dopt=A